Should we be worried about glaucoma? Why the prevalence of glaucoma is variably reported

Primary Health Care Research and Development

Volumn 10, Issue 4, 2009, Pages 343-356

  Worley, Anthea ^a   Grimmer Somers, Karen ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

glaucoma; incidence; metasynthesis; prevalence; risk factors

Indexed keywords

EID: 85011436342     PISSN: 14634236     EISSN: 14771128     Source Type: Journal    
DOI: 10.1017/S1463423609990193     Document Type: Article

References (41)

1. AGREE Collaboration. 2001: Appraisal of guidelines for research and evaluation (AGREE) instrument. Retrieved 18 February 2008 from http://www.agreecollaboration.com
2. AGREE Collaboration. 2003: Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care 12, 8–23.
3. Alexander C.L., Miller S.J., Abel S.R. 2002: Prostaglandin analog treatment of glaucoma and ocular hypertension. Annals of Pharmacotherapy 36, 504–511.
4. Amar M.B. 2006: Cannabinoids in medicine: a review of their therapeutic potential. Journal of Ethnopharmacology 105, 1–25.
5. American Academy of Ophthalmology (AAO). 2005: Primary angle closure preferred practice pattern. San Franciso, CA: American Academy of Ophthalmology.
6. American Optometric Association (AOA). 2002: Optometric clinical practice guideline: care of the patient with open angle glaucoma, second edition. St Louis, MO: American Optometric Association.
7. Australian Institute of Health and Welfare (AIHW). 2005: Vision problems among older Australians. AIHW Bulletin-27. Retrieved 8 August 2008 from http://www.aihw.gov.au/publications/index.cfm
8. Australian Bureau of Statistics (ABS). 2004: National Aboriginal and Torres Strait Islander Health Survey 2004–05. Retrieved 28 May 2008 from http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4715.0Main+Features12004-05?OpenDocument
9. Burr J., Azuara-Blanco A., Avenell A. 2004: Medical versus surgical interventions for open angle glaucoma. Cochrane Database of Systematic Reviews 8CD004399
10. Burr J.M., Mowatt G., Hernández R., Siddiqui M., Cook J., Lourenco T., Ramsay C., Vale L., Fraser C., Azuara-Blanco A., Deeks J., Cairns J., Wormald R., McPherson S., Rabindranath K., Grant A. 2007: The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technology Assessments 11, 1–206.
11. Costa V.P., Harris A., Stefansson E., Flammer J., Krieglstein G.K., Orzalesi N., Heijl A., Renard J.P., Serra L.M. 2003: The effects of antiglaucoma and systemic medications on ocular blood flow. Progress in Retinal and Eye Research 22, 769–805.
12. Denis P., Lafuma A., Khoshnood B., Mimaud V., Berdeaux G. 2007: A meta-analysis of topical prostaglandin analogues intraocular pressure lowering in glaucoma therapy. Current Medical Research and Opinion 23, 601–608.
13. Einarson T.R., Vicente C., Machado M., Covert D., Trope G.E., Iskedjian M. 2006: Screening for glaucoma in Canada: a systematic review of the literature. Canadian Journal of Ophthalmology 41, 709–721.
14. Fleming C., Whitlock E.P., Beil T., Smit B., Harris R.P. 2005: Screening for primary open-angle glaucoma in the primary care setting: an update for the US preventive services task force. Annals of Family Medicine 3, 167–170.
15. Foster P.J., Buhrmann R., Quigley H.A., Johnson G.J. 2002: The definition and classification of glaucoma in prevalence surveys. British Journal of Ophthalmology 86, 238–242.
16. Friedman D.S., Vedula S.S. 2006: Lens extraction for chronic angle-closure glaucoma. Cochrane Database of Systematic Reviews. Issue 13 Art. No. CD005555.
17. Fung A.T., Reid S.E., Jones M.P., Healey P.R., McCluskey P.J., Craig J.C. 2007: Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma. British Journal of Ophthalmology 91, 62–68.
18. Hatt S., Wormald R., Burr J. 2006: Screening for prevention of optic nerve damage due to chronic open angle glaucoma. Cochrane Database of Systematic Reviews. Issue 4 Art. No. CD006129.
19. Henness S., Harrison T.S., Keating G.M. 2007: Ocular carteolol – a review of its use in the management of glaucoma and ocular hypertension. Drugs & Aging 24, 509–528.
20. Holmstrom S., Buchholz P., Walt J., Wickstrom J., Aagren M. 2005: Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma. Current Medical Research and Opinion 21, 1875–1883.
21. Japan Glaucoma Society (JGS). 2004: Guidelines for glaucoma. Tokyo: Japan Glaucoma Society.
22. Law S.K., Li T. 2007: Acupuncture for glaucoma. Cochrane Database of Systematic Reviews. Issue 4 Art. No. CD006030.
23. Madden A.C., Simmons D., McCarty C.A., Khan M.A., Taylor H.R. 2002: Eye health in rural Australia. Clinical and Experimental Ophthalmology 30, 316–321.
24. Maier P.C., Funk J., Schwarzer G., Antes G., Falck-Ytter Y.T. 2005: Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. British Medical Journal 331, 134–139.
25. Mitchell P., Smith W., Attebo K., Healey P. 1996: Prevalence of open-angle glaucoma in Australia: the Blue Mountains eye study. Ophthalmology 103, 1661–1669. 8874440
26. Moore W., Nischal K.K. 2007: Pharmacologic management of glaucoma in childhood. Pediatric Drugs 9, 71–79.
27. Moher D., Klassen T.P., Schulz K.F., Berlin J.A. 2000: What contributions do languages other than English make on the results of meta-analyses? Journal of Clinical Epidemiology 53, 964–972.
28. Moher D., Pham B., Lawson M.L., Klassen T.P. 2003: The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technology Assessment 7, 1–90. 14670218
29. Møller A.P., Jennions M.D. 2001: Testing and adjusting for publication bias. Trends in Ecology & Evolution 16, 580–586.
30. National Health and Medical Research Council (NHMRC). 2005: NHMRC additional levels of evidence and grades for recommendations for developers of guidelines: stage 2 consultation. Retrieved 8 August 2008 from http://www.nhmrc.gov.au/guidelines/_files/Stage%202%20Consultation%20Levels%20and%20Grades.pdf, www.nhmrc.gov.au
31. Obstbaum S.A., Cioffi G.A., Krieglstein G.K., Fennerty M.B., Alm A., Araie M., Carassa R.G., Greve E.L., Hitchings R.A., Kaufman P.L., Kitazawa Y., Pongpun P.R., Susanna R. Jr, Wax M.B., Zimmerman T.J. 2004: Gold standard medical therapy for glaucoma: defining the criteria identifying measures for an evidence-based analysis. Clinical Therapeutics 26, 2102–2120.
32. Plosker G.L., Keam S.J. 2006: Bimatoprost – a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension. PharmacoEconomics 24, 297–314.
33. Rolim de Moura C., Paranhos A. Jr, Wormald R. 2007: Laser trabeculoplasty for open angle glaucoma (review). Cochrane Database of Systematic Reviews. Issue 4 Art. No. CD003919.
34. Rowe S., MacLean C.H., Shekelle P.G. 2004: Preventing visual loss from chronic eye disease in primary care: scientific review. Journal of the American Medical Association 291, 1487–1495.
35. Royal College of Ophthalmologists (RCO). 2004: Guidelines for the management of open angle glaucoma and ocular hypertension. London: Royal College of Ophthalmologists.
36. Saw S.M., Gazzard G., Friedman D.S. 2003: Interventions for angle-closure glaucoma: an evidence-based update. Ophthalmology 110, 1869–1878.
37. Schmier J.K., Halpern M.T., Jones M.L. 2007: The economic implications of glaucoma – a literature review. PharmacoEconomics 25, 287–308.
38. South-East Asia Glaucoma Interest Group (SEAGIG). 2003: Asia Pacific glaucoma guidelines. Sydney: South-East Asia Glaucoma Interest Group.
39. Sycha T., Vass C., Findl O., Bauer P., Groke I., Schmetterer L., Eichler H. 2003: Interventions for normal tension glaucoma. Cochrane Database of Systematic Reviews. Issue 1 Art. No. CD002222.
40. US Preventive Services Task Force (USPSTF). 2005: Screening for glaucoma: recommendation statement. Rockville, MD: Agency for Healthcare Research and Quality, 1–16.
41. Weih L., Nanjan M., McCrty C., Taylor H. 2001: Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108, 1966–1972.